Stephen Brown and Wei Tian, Encap Drug Delivery03.09.16
Pharmaceutical and nutritional companies today require a diverse range of technologies and dosage forms to develop customized solutions that improve delivery of their products to the body. New compounds in the pharmaceutical pipeline are increasingly complex and typically require enabling technologies to address challenges such as solubility, permeability, stability, metabolism, regional absorption, or food/pH sensitivity. Advancing these compounds also can require specialized processing techniques and often require high containment to handle an increasing number of highly potent applications.
Liquid fill hard capsules (LFHC) technology is one delivery method that is popular due to its simplicity in manufacturing design and technology transfer process, and its versatility in providing sophisticated solutions for a vast range of pharmaceutical formulation and delivery needs. LFHC technology is increasingly utilized to address key formulation challenges in advancing new chemical entities or improving existing products, including enhancing bioavailability, highly potent and low dose applications, combination products, intestinal targeting and colonic delivery. Thi
Liquid fill hard capsules (LFHC) technology is one delivery method that is popular due to its simplicity in manufacturing design and technology transfer process, and its versatility in providing sophisticated solutions for a vast range of pharmaceutical formulation and delivery needs. LFHC technology is increasingly utilized to address key formulation challenges in advancing new chemical entities or improving existing products, including enhancing bioavailability, highly potent and low dose applications, combination products, intestinal targeting and colonic delivery. Thi
Continue reading this story and get 24/7 access to Contract Pharma for FREE
FREE SUBSCRIPTION
